“…Thus, TFF1 is a candidate gastric-specific tumor suppressor to protect the mucosa against acid, digestive enzymes and pathogens, such as Helicobacter pylori (Rio et al, 1988;Lefebvre et al, 1996;Van De Bovenkamp et al, 2005). In contrast, TFF1 is absent in normal colon but is induced at high levels in Crohn disease and colorectal cancers (Emami et al, 2004). Recent studies incriminate TFF1 and other TFFs in the neoplastic progression of the digestive system, according to their scattering, proinvasive and proangiogenic activities in vitro and in vivo (Emami et al, 2001;Rodrigues et al, 2001Rodrigues et al, , 2003bRivat et al, 2005).…”